NCT05330676

Brief Summary

This study will examine the differences in microcirculatory function and mitochondrial respiration in patients with shock after cardiovascular surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

April 9, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 15, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

May 2, 2024

Completed
Last Updated

May 2, 2024

Status Verified

May 1, 2024

Enrollment Period

2.6 years

First QC Date

April 9, 2022

Results QC Date

March 25, 2024

Last Update Submit

May 1, 2024

Conditions

Keywords

microcirculationmitochondrial respirationcirculatory shockcardiovascular surgeryresuscitation

Outcome Measures

Primary Outcomes (1)

  • Perfused Vessel Denisty (PVD)

    Perfused vessel density (PVD) was measured with incident darkfield microscopy (units mm/mm\^2)

    PVD was measured at baseline (immediately prior to surgery), at ICU admission, approximately 4 hours after surgery, then at 24 hours.

Study Arms (2)

No shock

Patients who have no evidence of clinical malperfusion or require vasoactive agents after cardiac surgery.

Procedure: coronary artery bypass grafting, valve repair/replacement

Shock

Patients who have evidence of clinical malperfusion or require vasoactive agents after cardiac surgery.

Procedure: coronary artery bypass grafting, valve repair/replacement

Interventions

cardiovascular surgery with cardiopulmonary bypass

No shockShock

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with cardiovascular disease

You may qualify if:

  • Adult patients (\>18 years old)
  • Receiving elective coronary artery bypass graft (CABG)
  • Receiving valvular surgery requiring cardiopulmonary bypass

You may not qualify if:

  • Unable to tolerate sublingual microcirculatory flow imaging (e.g., non-intubated patients dependent upon oxygen by facemask, poor mouth opening)
  • receiving an emergent procedure
  • have an actively treated malignancy
  • mitochondrial disorder
  • receiving surgery requiring deep hypothermic circulatory arrest.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Related Publications (1)

  • Greenwood JC, Talebi FM, Jang DH, Spelde AE, Gordon EK, Horak J, Acker MA, Kilbaugh TJ, Shofer FS, Augoustides JGT, Brenner JS, Muzykantov VR, Bakker J, Abella BS. Anaerobic Lactate Production Is Associated With Decreased Microcirculatory Blood Flow and Decreased Mitochondrial Respiration Following Cardiovascular Surgery With Cardiopulmonary Bypass. Crit Care Med. 2024 Aug 1;52(8):1239-1250. doi: 10.1097/CCM.0000000000006289. Epub 2024 Apr 5.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Peripheral blood mononuclear cells, plasma

MeSH Terms

Conditions

ShockCardiovascular DiseasesCritical Illness

Interventions

Coronary Artery BypassReplantation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Intervention Hierarchy (Ancestors)

Myocardial RevascularizationCardiac Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeVascular GraftingVascular Surgical ProceduresThoracic Surgical ProceduresTransplantation

Results Point of Contact

Title
John C. Greenwood, MD, MS
Organization
University of Pennsylvania

Study Officials

  • John C. Greenwood

    Perelman School of Medicine at the University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Emergency Medicine, Anesthesiology & Critical Care

Study Record Dates

First Submitted

April 9, 2022

First Posted

April 15, 2022

Study Start

September 1, 2020

Primary Completion

April 1, 2023

Study Completion

April 1, 2023

Last Updated

May 2, 2024

Results First Posted

May 2, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

The protocol for this trial will be published in a peer reviewed journal. The anonymized dataset supporting the results of this report will be available via the Zenodo research data repository.

Shared Documents
STUDY PROTOCOL, SAP, CSR

Locations